Search Result "MPTP"
α-Synuclein- and MPTP-Generated Rodent Models of Parkinsons Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2010 Page: 482-490
Author(s): Gianfranco Bazzu, Giammario Calia, Giulia Puggioni, Ylenia Spissu, Gaia Rocchitta, Patrizia Debetto, Jessica Grigoletto, Morena Zusso, Rossana Migheli, Pier Andrea Serra, Maria Speranza Desole, Egidio Miele
Evaluation of Neurobehavioral and Biochemical Parameters of Poly- Herbal Formulation on MPTP-Intoxicated Mice for the Treatment of PD
Journal: Current Bioactive Compounds
Volume: 16 Issue: 9 Year: 2020 Page: 1290-1298
Author(s): Amit K. Srivastava,Arif Naseer,Amresh Gupta
Potent Neuroprotective Activity of Monoterpene Derived 4-[(3aR,7aS)- 1,3,3a,4,5,7a-Hexahydro-3,3,6-trimethylisobenzofuran-1-yl]-2-methoxyphenol in MPTP Mice Model
Journal: Letters in Drug Design & Discovery
Volume: 11 Issue: 5 Year: 2014 Page: 611-617
Author(s): Alla V. Pavlova, Irina V. Il'ina, Ekaterina A. Morozova, Dina V. Korchagina, Svetlana Yu. Kurbakova, Irina V. Sorokina, Tatyana G. Tolstikova, Konstantin P. Volcho, Nariman F. Salakhutdinov
Comparative Assessment of Polyherbal Formulation and Mucuna pruriens Extract as Neuroprotectant by Using MPTP Screening Mouse Model ofParkinsonâs Disease
Journal: Current Bioactive Compounds
Volume: 18 Issue: 7 Year: 2022 Page: 78-86
Author(s): Amit Kishor Srivastava
The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 489-507
Author(s): Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina, Rita Raisman-Vozari
Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2
Journal: Current Neurovascular Research
Volume: 13 Issue: 2 Year: 2016 Page: 115-120
Author(s): Sen Liu,Bei Cui,Zhen-xia Dai,Peng-ke Shi,Zhao-hui Wang,Yuan-yuan Guo
Neurotoxic Mechanism and Shortcomings of MPTP, 6-OHDA, Rotenone and Paraquat-induced Parkinsonâs Disease Animal Models
Journal: Venoms and Toxins
Volume: 1 Issue: 1 Year: 2021 Page: 27-40
Author(s): Samuel Kumi Okyere,Chaorong Zeng,Dong Yue,Yanchun Hu
A PPAR-β/δ Agonist is Neuroprotective and Decreases Cognitive Impairment in a Rodent Model of Parkinsonâs Disease
Journal: Current Neurovascular Research
Volume: 11 Issue: 2 Year: 2014 Page: 114-124
Author(s): Nihar R. Das,Rahul P. Gangwal,Mangesh V. Damre,Abhay T. Sangamwar,Shyam S. Sharma
Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) ActivatorAmeliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinsonâs Disease
Journal: Current Neurovascular Research
Volume: 18 Issue: 5 Year: 2021 Page: 497-507
Author(s): Shyam Sunder Sharma,Mahendra Bishnoi,Pragyanshu Khare,Bhupesh Vaidya,Nihar Ranjan Das
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 6 Year: 2021 Page: 514-525
Author(s): Tatiana A. Fedotcheva,Nadezhda I. Fedotcheva